MPV obstruction is recognized as a complete contraindication.
Trial staff will also ask consenting parents and guardians to complete a contraindications checklist (adapted from the Childsmile Consent Form for Toothbrushing & Fluoride Varnish [version 7.1]).
Conclusion ECMO could be used as a bridge to evaluate temporary contraindicated patients for HELT and allowed to transplant them after complete correction of the contraindications.
This study excluded patients with severe immobility (H&Y stage 5) because of their inability to complete the TUG test, contraindications for MRI, and inability to give consent due to the presence of severely debilitating diseases.
At this visit study staff will confirm eligibility before the baseline dental examination is carried out by a study dental practitioner (e.g., signed consent form is in place, enquiry form regarding contraindications is complete and the child has no obvious temporary infections or injuries which would lead to exclusion on the day).
ECV is indicated for women presenting with a confirmed singleton breech fetus at ≥ 36 completed weeks with no contraindications for vaginal delivery [ 16, 17].
Parents/guardians will be sent a self-complete version of the Contraindications checklist (adapted from the Childsmile Consent Form for Toothbrushing & Fluoride Varnish [version 7.1]) and a covering letter.
Exclusion criteria included physician diagnosed arthritis, prior surgical intervention to the knee, previous significant knee injury requiring non weight bearing therapy, knee pain precluding weight-bearing activity for >24 h or prescribed analgesia, malignancy, inability to complete the study or contraindication to MRI.
Our base case focuses on a parturient presenting with an ultrasound confirmed singleton breech fetus at ≥ 36 completed weeks gestation, with no contraindications for vaginal delivery.
Our hypothetical base case (a parturient presenting with a confirmed singleton breech fetus at ≥ 36 completed weeks gestation with no contraindications for vaginal delivery) is similar to the type of patient the ACOG recommends for trial of ECV [ 12, 18].
